News Release | UpDoc
Summary
PALO ALTO, January 4th, 2024 - UpDoc, the first company with a conversational AI platform that manages medication prescriptions, today exited stealth to announce a strategic funding round led by Polaris Partners with participation from Eli Lilly & Company, Mayo Clinic and Oxeon. This follows landmark research conducted at Stanford Medicine and paves the way for additional collaborations with Microsoft, Google, Santa Clara County Independent Physician Association (SCCIPA), UCSF Health, and the American Heart Association. All care delivered through the AI is prescribed by physicians or clinical pharmacists who oversee the platform.Taking place during a time of market uncertainty, the successful fundraise is evidence that investors continue to see the opportunity in early-stage game-changing AI companies, particularly those founded by high-conviction teams with a hands-on approach.UpDoc has secured strategic partnerships with elite organizations including Microsoft, Google Cloud and SCCIPA for research, funding, development, and cloud and AI infrastructure aimed at ushering in a new era of tech-enabled care. Powered by Large Language Models (LLMs) and a proprietary clinical intelligence platform, UpDocs engagement engine incorporates health literacy, illness perception and cultural perspectives to bridge gaps in health equity. By scaling provider reach, the AI assistant is also designed to improve efficiency and reduce clinical burnout.